TOI Key Statistics, Chart & Performance
The current stock price of TOI is 4.31 USD. In the past month the price increased by 27.99%. In the past year, price increased by 1249.02%.
TOI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 18.52 | 109.31B | ||
| THC | TENET HEALTHCARE CORP | 13.1 | 17.87B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 10.15 | 13.19B | ||
| EHC | ENCOMPASS HEALTH CORP | 20.31 | 10.56B | ||
| ENSG | ENSIGN GROUP INC/THE | 28.24 | 10.21B | ||
| PACS | PACS GROUP INC | 28.92 | 6.48B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 2.66B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 15.93 | 2.55B | ||
| NHC | NATIONAL HEALTHCARE CORP | 19.18 | 2.00B | ||
| SGRY | SURGERY PARTNERS INC | 20.14 | 2.03B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 17.74 | 1.89B | ||
| ARDT | ARDENT HEALTH INC | 4.3 | 1.32B |
Related stock screener links
About TOI
Company Profile
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 825 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Company Info
ONCOLOGY INSTITUTE INC/THE
18000 Studebaker Rd, Suite 800
Cerritos CALIFORNIA US
CEO: Steven Hochberg
Employees: 825
Phone: 15627353226
ONCOLOGY INSTITUTE INC/THE / TOI FAQ
Can you describe the business of ONCOLOGY INSTITUTE INC/THE?
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 825 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Can you provide the latest stock price for ONCOLOGY INSTITUTE INC/THE?
The current stock price of TOI is 4.31 USD. The price increased by 5.9% in the last trading session.
Does ONCOLOGY INSTITUTE INC/THE pay dividends?
TOI does not pay a dividend.
What is the ChartMill technical and fundamental rating of TOI stock?
TOI has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Should I buy TOI stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TOI.
What is the expected growth for TOI stock?
The Revenue of ONCOLOGY INSTITUTE INC/THE (TOI) is expected to grow by 20.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for ONCOLOGY INSTITUTE INC/THE?
ONCOLOGY INSTITUTE INC/THE (TOI) currently has 825 employees.
TOI Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to TOI. When comparing the yearly performance of all stocks, TOI is one of the better performing stocks in the market, outperforming 99.83% of all stocks.
TOI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TOI. TOI has a bad profitability rating. Also its financial health evaluation is rather negative.
TOI Financial Highlights
Over the last trailing twelve months TOI reported a non-GAAP Earnings per Share(EPS) of -0.64. The EPS increased by 16.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.41% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TOI Forecast & Estimates
8 analysts have analysed TOI and the average price target is 6.63 USD. This implies a price increase of 53.83% is expected in the next year compared to the current price of 4.31.
For the next year, analysts expect an EPS growth of -36.9% and a revenue growth 20.72% for TOI